Atlantic Equities analyst Steve Chesney maintains Merck & Co (NYSE:MRK) with a Overweight and raises the price target from $116 to $122.
Has Robinhood’s Stock Fallen Far Enough To Become An Acquisition Target? Josh Brown Thinks So
Growth stocks have fallen out of favor over the last few months amid expectations for tighter Federal Reserve policy. With some stocks having fallen 70% or 80% from their highs, Ritholtz Wealth Management's Josh Brown expects to see more acquisitions in the near term.
